Aren't you amazed about how fast the world has come together to find a collective solution for COVID-19? We have learned in the past months that we can compress the traditional vaccine paradigm, which is between 5 to 10 years to just 4 to 18 months.
The tremendous impact of the COVID crisis has significantly raised the global expectations and appreciation for innovation, digital, and excellence, which leads us to the question: what will the new normal be?
That's why there has never been a better time to connect, even virtually, in order to shape the transformation of the pharmaceutical industry with knowledge and expertise across the entire lifecycle.
Join us at the 2020 ISPE Biotechnology Virtual Conference on 7–8 October to hear from the experts as they discuss:
Your event experience includes access to two ATMP-focused workshops where you will discuss, debate, and identify potential deliverables.
Included in your conference registration are exclusive facilities tour of Produlab Pharma (PP), Catalent, and Takeda.
Designed to be highly interactive and hosted on a state-of-the-art digital platform, the 2020 ISPE Biotechnology Virtual Conference delivers the same high-quality content and premier engagement opportunities that you expect from this signature ISPE event.
I truly believe you and your team will find this event invaluable based on the opportunity for regulatory duty and comprehensive agenda addressing timely, industry-critical topics.
In addition, we are pleased to announce pricing for the 2020 ISPE Biotechnology Virtual Conference ranging from € 35 to € 495.
I look forward to seeing you there also for virtual networking!
Through the ISPE Foundation Professional Development Grant program, Silas Tamufor attended the 2023 ISPE Annual Meeting & Expo in October 2023. Tamufor is a PhD student and ISPE Boston Chapter member who began serving as the ISPE Boston Educational Programs Committee Chair in December 2023. He, along with 87 other students and recent graduates, attended the conference thanks to the...
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...